Predicting Response to Incretin-Based Therapy

Research and Reports in Endocrine Disorders
doi 10.2147/rred.s16282
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Which Incretin-Based Therapy for Type 2 Diabetes?

The Lancet
Medicine
2014English

Predicting Response to Immunosuppressive Therapy in Childhood Aplastic Anemia

Haematologica
Hematology
2011English

Oral Galactose Provides a Different Approach to Incretin-Based Therapy of Alzheimer's Disease

Journal of Neurology & Neuromedicine
2018English

Predicting Response/Resistance to Endocrine Therapy for Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2005English

Assesment of the Medical and Social Benefits of Incretin-Based Therapy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Role of Incretin‐based Therapy in Hospitalized Patients With Type 2 Diabetes

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2019English

MRI in Predicting the Response of Gastrointestinal Stromal Tumor to Targeted Therapy: A Patient-Based Multi-Parameter Study

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Incretin-Based Therapy and Risk of Acute Pancreatitis: A Nationwide Population-Based Case-Control Study

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2015English

The Importance of Myocardial Contractile Reserve in Predicting Response to Cardiac Resynchronization Therapy

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy